1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

21 Apr 2022
Admin
News Article

Dragonfly Expands Research Collaboration With Abbvie To Develop Novel Therapeutic Candidates For Immune-Mediated Diseases

Dragonfly Therapeutics. (Dragonfly), A Biotechnology Company, Announced An Expansion Of Its Research Collaboration With Abbvie To Discover And Develop Dragonfly'S Novel Immunotherapies For New Targets In Autoimmune And Fibrotic Diseases.Abbvie Successfully Licensed Its First Trinket Drug Candidate From Dragonfly, Part Of A Multi-Target Collaboration Initiated In November 2019, In January 2021."Abbvie Is Committed To Delivering Transformative Treatment Options For Patients Suffering From Autoimmune And Fibrotic Diseases," Said Dr. Jonathon Sedgwick, Vice President And Global Head Of Discovery Research At Abbvie. "We Have Seen Strong Progress In Our Current Collaboration With Dragonfly Focused On Their Trinket Technology And Are Pleased To Expand Our Partnership To Include Additional Immunology Targets Of Interest To Abbvie.""Abbvie Is A Global Leader In Treating Immune-Mediated Diseases, And They Continue To Be A Terrific Partner" Said Bill Haney, Co-Founder And Chief Executive Officer Of Dragonfly, "We Look Forward To Building On Our Successful Collaboration, And Rapidly Progressing With The Abbvie Team To Advance New Treatment Options For Patients."Under The Agreement, Dragonfly Will Grant Abbvie The Option To License Exclusive Worldwide Intellectual Property Rights To Multiple New Candidates Developed Using Dragonfly'S Trinket Technology Platform. Abbvie Will Pay Dragonfly An Upfront Payment, Future Success-Based Milestone Payments And Royalties.Dragonfly Therapeutics, Inc. Is A Clinical-Stage Biopharmaceutical Company Committed To Discovering, Developing And Commercializing Therapies That Use Its Novel Trinket Technology To Harness The Body'S Innate Immune System To Bring Breakthrough Treatments To Patients.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!